Reaction
Glioma reporting signals
As of the last recalculation, Glioma appears in 633 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is MERCAPTOPURINE (PRR 139.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mercaptopurine | 66 | 139.6 | 140.1 |
| Temozolomide | 55 | 93.9 | 94.1 |
| Trametinib | 49 | 72.2 | 72.3 |
| Cytarabine | 73 | 45.0 | 45.1 |
| Vincristine Sulfate | 35 | 41.5 | 41.6 |
| Dabrafenib | 25 | 40.6 | 40.6 |
| Bevacizumab | 96 | 29.9 | 29.9 |
| Cortisone Acetate | 11 | 29.8 | 29.8 |
| Cyclophosphamide Injection, Solution | 89 | 19.1 | 19.1 |
| Cyclophosphamide | 89 | 19.1 | 19.1 |
| Cyclophosphamide For Injection | 89 | 19.1 | 19.1 |
| Doxorubicin | 38 | 14.9 | 14.9 |
| Somatropin | 20 | 9.2 | 9.2 |